Publication: Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus
Loading...
Date
2018-01-01
Authors
Kilicarslan, Rukiye
Cakirca, MUSTAFA
Aydin, SİNEM
OZKAN, Tuba
KOCAMAN, Orhan
Yolbas, Servet
Zorlu, MEHMET
Karatoprak, CUMALİ
Kiskac, MUHARREM
CIKRIKCIOGLU, Mehmet Ali
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Objective: This study investigated how vildagliptin (a di-peptidyl peptidase 4 inhibitor) affects portal vein pressure and hepatosteatosis in patients with type 2 diabetes mellitus.
Description
Keywords
Citation
Karatoprak C., Kilicarslan R., Cakirca M., Aydin S., OZKAN T., KOCAMAN O., Yolbas S., Zorlu M., Kiskac M., CIKRIKCIOGLU M. A. , et al., -Vildagliptin Treatment on the Portal Venous Pressure and Hepatosteatosis in Patients with Type 2 Diabetes Mellitus-, BEZMIALEM SCIENCE, cilt.6, ss.1-5, 2018